Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (364)
  2. Journal Article (358)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (790)
  2. Department of Medicine (790)
  3. Gastrointestinal Oncology Service (790)
  4. Solid Tumor Oncology Division (790)
  5. Epidemiology and Biostatistics (178)
  6. Surgery (168)

More Groups

People
  1. Ghassan Abou-Alfa (156)
  2. Kenneth Yu (121)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (94)
  6. William Jarnagin (84)

More People

Years
  1. 2025 (38)
  2. 2024 (75)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (294)
  2. Annals of Oncology (48)
  3. Cancer (27)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (308)
  2. Oxford University Press (71)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (42)
  6. American Association for Cancer Research (40)

More Publishers

Results (790)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The frequency of second primary malignancies and colonic polyps in Lynch syndrome with MSI tumors following immune checkpoint blockade
    Meeting Abstract

    Harrold, E.; Patel, Z.; Maio, A.; Cercek, A.; Yaeger, R.; Segal, N. H.; Reidy, D. L.; O'Reilly, E. M.; Desai, A. M.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma
    Meeting Abstract

    Balachandran, V. P.; Rojas, L. A.; Sethna, Z.; Soares, K.; Derhovanessian, E.; Mueller, F.; Yadav, M.; Basturk, O.; Gonen, M.; Wei, A. C. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Methylation analyses reveal promoter hypermethylation as a rare cause of “second hit” in germline BRCA1-associated pancreatic ductal adenocarcinoma
    Journal Article

    Zheng-Lin, B.; Rainone, M.; Varghese, A. M.; Yu, K. H.; Park, W.; Berger, M.; Mehine, M.; Chou, J.; Capanu, M.; Mandelker, D.; more...
    Molecular Diagnosis and Therapy (2022)

    Fulltext@MSK | Save
  • Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system
    Journal Article

    Tringale, K. R.; Tyagi, N.; Reyngold, M.; Romesser, P. B.; Wu, A.; O'Reilly, E. M.; Varghese, A. M.; Godoy Scripes, P.; Khalil, D. N.; Park, W.; more...
    Physics and Imaging in Radiation Oncology (2022)

    Fulltext@MSK | Save
  • Clinico-genomic characterization of ATM and HRD in pancreas cancer: Application for practice
    Journal Article

    Park, W.; O'Connor, C. A.; Bandlamudi, C.; Forman, D.; Chou, J. F.; Umeda, S.; Reyngold, M.; Varghese, A. M.; Keane, F.; Balogun, F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Supporting patients with cancer after Dobbs v. Jackson Women's Health Organization
    Editorial

    Shuman, A. G.; Aapro, M. S.; Anderson, B.; Arbour, K.; Barata, P. C.; Bardia, A.; Bruera, E.; Chabner, B. A.; Chen, H.; Choy, E.; more...
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Venous thromboprophylaxis in surgical oncology patients: The importance of risk assessment in the context of limited evidence
    Correspondence

    Snyder, R. A.; O'Reilly, E. M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Helping patients understand pancreatic cancer using animated pancreas patient education with visual formats of learning
    Journal Article

    Munigala, S.; Gardner, T. B.; O'Reilly, E. M.; Fernández-Del Castillo, C.; Ko, A. H.; Pleskow, D.; Vollmer, C. M. Jr; Searle, N. A.; Bakelman, D.; Holt, J. M.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: The A021501 phase 2 randomized clinical trial
    Journal Article

    Katz, M. H. G.; Shi, Q.; Meyers, J.; Herman, J. M.; Chuong, M.; Wolpin, B. M.; Ahmad, S.; Marsh, R.; Schwartz, L.; Behr, S.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Radiation therapy (RT) quality assurance (QA) analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas (PDAC)
    Meeting Abstract

    Tchelebi, L.; Smith, K. S.; Shi, Q.; Fitzgerald, T.; Chuong, M. D.; Zemla, T.; O'Reilly, E.; Meyerhardt, J.; Koay, E. J.; Leif, J. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save